Empowering Africa: The Launch of the Africa Vaccine Manufacturers Initiative.

Building a Self-Reliant Future: AVMI Unites Stakeholders to Develop and Sustain African Vaccine Production for Routine and Emergency Health Needs.

AVMIBuilding Africa’s Vaccine Independence.

 A Call to Action for Sustainable Manufacturing.

Africa represents 14% of the world’s population and it is estimated that by 2050 25% of the global population will live in Africa. Currently less than 1% of the vaccines used in Africa are produced in Africa.

The importance of developing vaccine manufacturing capacity in Africa was underlined by the Global Vaccine Action Plan resolution at the 2015 World Health Assembly where there was a call for Member States to seek opportunities for national and regional vaccine production and to investigate procurement options for improved access to and supply of vaccines. In addition to improving response to emergency situations, African vaccine manufacturing could improve security and sustainability of vaccine supply, respond to unmet health needs of a growing population and aid socioeconomic development in Africa.

projectsTransformative projects
powered by Neural Networks